Literature DB >> 11056833

New-onset diabetes mellitus associated with quetiapine.

R M Procyshyn, S Pande, G Tse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11056833

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  7 in total

Review 1.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 4.  [Diabetes mellitus as a complication of treatment with atypical neuroleptics. Possible pathomechanisms and treatment recommendations].

Authors:  H Jahn; T Schneider
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 5.  Hyperglycemia with antipsychotic treatment.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 6.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 7.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.